posted
I belive this will be the stock of the year. Small float steady volum and climbing. Do your DD, at the end of November was .16 cents, now is .43 and climbing. Great product O24 pain killer, great management, the last comp. with the same CEO went from .90 cents to $42(yes forty two dollars). Chek them out you will be surprised.
Cheers!!
Max
Posts: 8 | From: NY | Registered: Jan 2005
| IP: Logged |
posted
Yeah its a good stock in my opinion, i did some dd on it and looks good and lots of people are talking about it to!!
i bought 3 stocks today EZTO, GWNI, AND SWME
all doing greatly for me, this one is the only one thats not up big, and thats what i expected!!
this one is going up slow and stedily which is what i like i have some big expectations for this one!! i think it can get to $2 in a month or 2!!!
good find guys
-------------------- The sun even shines on a dogs ass someday....Patience my friend your day will come one day! Posts: 429 | Registered: Jan 2005
| IP: Logged |
posted
TORONTO--(BUSINESS WIRE)--Dec. 30, 2004--Swiss Medica (OTCBB:SWME - News) is pleased to announce it has signed definitive agreements for debt financing, resulting in gross proceeds of US$1.5 million to fund the inventory and marketing requirements for the National U.S. launch of the Company's flagship O24(TM) pain relief product.
"This debt financing allows us to execute the launch phase of our ambitious marketing plan in the United States by using the same cost-efficient media strategy that has brought the O24 product a spectacular and devoted following in Canada," said Chief Executive Officer Raghu Kilambi. "Funds were raised from a group of institutional and high net worth investors with minimal equity dilution."
Full details of the financing will be incorporated in the Company's 8-K filing with the U.S. Securities and Exchange Commission.
By Michael Reynolds
On September 30th, Swiss Medica (OTC BB: SWME) was handed a godsend. Merck & Co announced a worldwide voluntary recall of its widely popular pain relief prescription medicine, Vioxx®. Swiss Medica scrambled to meet the avalanche of consumer demand for its all-natural O24™ topical pain reliever. Canada’s leading pharmacy chain quickly re-ordered after initial shipments were sold out. At the national AARP event in Las Vegas, seniors purchased up to several months supply of O24™ in case the product was not readily available to them in their neighborhood drugstore. “Recent congressional hearings and FDA statements about the safety concerns of arthritis, and other pain, pills gave Swiss Medica a strong sales surge early in this quarter,” said CEO Raghu Kilambi. “The more educated, health-conscious consumer wants a pain-relief product without the dangerous side effects so he or she can remain active and robust.” Sales of O24™ have increased exponentially quarter to quarter over the past year, and are could double in Q4 over the previous quarter.
TORONTO--(BUSINESS WIRE)--Dec 22, 2004 - Swiss Medica (OTCBB:SWME) is pleased to announce that the randomized double blind clinical trial using the O24(TM) pain relief product on patients suffering from fibromyalgia has been completed and a final report will be issued in January.
The clinical trials, which began October 1st, were recently concluded, according to Dr. Gordon Ko, medical director of the Canadian Centre for Integrative Medicine, who conducted the study. The results are currently being analyzed by the Institute of Clinical Evaluative Studies (ICES) in Toronto. There are 21,000 pages of data to be analyzed on the 150 fibromyalgia patients who were tested with the O24 product and a placebo over an extended period.
At present, there are no medications approved by the U.S. Food and Drug Administration (FDA) for treating fibromyalgia, a common and chronic disorder characterized by widespread muscle pain, fatigue, and multiple tender points.
ORONTO, ONTARIO, Dec 20, 2004 (CCNMatthews via COMTEX) -- Swiss Medica (OTCBB:SWME) has accelerated its efforts to reach physicians and healthcare professionals with the Company's O24(TM) pain relief product, following Friday's warning by the Food and Drug Administration that physicians consider alternatives to Pfizer's popular arthritis medication, and Cox-2 inhibitor, Celebrex(R); the Arthritis Foundation's recent caution in the use of any Cox-2 inhibitor; and a letter, to be published in the December 23rd issue of New England Journal of Medicine, by Vanderbilt University researchers, which warns clinicians against prescribing another Pfizer Cox-2 inhibitor, Bextra(R), "except in extraordinary circumstances."
"For the less severe cases of arthritis and other chronic pain ailments, I urge physicians, and other healthcare practitioners, to consider the non-synthetic nature of the O24(TM) pain relief product," said Allan N. Fields, D.O., who recently edited an information guide about the O24(TM) Essential Oil Pain Neutralizer, entitled Natural Relief for Musculoskeletal Pain. "I recommend O24(TM) as a topical delivery system, which may help reduce the frequent use of oral pain medications. Many patients can apply O24(TM) to their pain area for fast-acting and long-lasting pain relief without interfering with their current prescription medication. O24(TM) may be a safe solution for many who worry about the increased risk of heart attack from the Cox-2 inhibitor class, or the deleterious impact on the stomach lining from anti-inflammatory medicines such as aspirin, ibuprofen or naproxen, as reported in the media.
-------------------- Bring me a shrubbery Posts: 69 | From: Maine | Registered: Jun 2004
| IP: Logged |
posted
i think this week will be a good week for this one. sold off alot friday but came back end of day.
Posts: 50 | From: michigan | Registered: Jan 2005
| IP: Logged |
posted
The only thing I don't like about this stock is the fact that the Co chose a real none popular sports figure Larry Holmes as a spokes person. {he just doen't have what it takes as a spokes person not a very likeable person and not very credible} I actually think that alot of people won't buy this product because of him. Now if it was Geoge Formen I would give it a thums up. Any thoughts on this comment.
Posts: 517 | From: jupiter, florida, usa | Registered: Apr 2004
| IP: Logged |
posted
News Out!! --------------------- Rite Aid Drugstore Chain To Carry Swiss Medica's O24 Pain Relief Product Tuesday January 18, 8:00 am ET
TORONTO--(BUSINESS WIRE)--Jan. 18, 2005--Swiss Medica Inc. (OTCBB:SWME - News) is pleased to announce the Rite Aid Corporation, the third largest U.S. drugstore chain by store count, will begin carrying the Company's flagship pain relief product, the O24 Essential Oil Pain Neutralizer, across its national store footprint. Swiss Medica will commence its marketing, public relations and sampling campaign in conjunction with the arrival of the Company's pain relief product on Rite Aid shelves. Swiss Medica will use its proven marketing and sampling strategies, which had been fine-tuned during the national Canadian launch of the O24 product in the fall of 2004. Multi-media advertising will be launched nationally to provide full coverage in all Rite Aid markets, especially major metropolitan areas such as New York City, Los Angeles, Philadelphia, Washington D.C., San Francisco, and Detroit. Tom Quinn, Swiss Medica's VP of U.S. Operations said, "We are proud to have Rite Aid as our newest customer and our first U.S. national drugstore chain. Rite Aid's 3,300 plus stores gives them strong presence in many of the country's largest markets and will give millions of Americans the opportunity to buy O24- the new, patented, effective and safe way to relieve their pain and resume more normal lives."
About Rite Aid Corporation
Rite Aid Corporation operates retail drugstores in the United States. During the fiscal year ended February 28, 2004 (fiscal 2003), the Company operated 3,382 stores located in 28 states across the country and in the District of Columbia. According to Chain Drug Review magazine, Rite Aid's revenues stood at $16.87 billion for FY2003.
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.O24zone.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States, Canada and in Europe. O24(TM) is widely available throughout Canada in leading pharmacies and natural food stores. It is currently available in Happy Harry's Discount Drugstores in the United States, or by visiting www.O24zone.com, for ordering details and store locators.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.
Swiss Medica Inc. (OTC Bulletin Board:SWME - News)
-------------------------------------------------------------------------------- Contact: Swiss Medica Inc. David Jones Investor Relations Contact 1-866-485-4243 OR Blue Skye PR, Inc. Sky Wallen Press Contact (813) 732-6869 blueskyeinc@yahoo.com www.blueskyeinc.comPosts: 424 | From: Baltimore, MD | Registered: Apr 2004
| IP: Logged |
posted
Huge News today - selling in Wal-Mart nationwide in Canada: ========================= Wal-Mart Canada Corp. Now Offering Swiss Medica's O24 Pain Neutralizer Thursday August 4, 6:00 am ET
TORONTO--(BUSINESS WIRE)--Aug. 4, 2005--Swiss Medica, Inc. (OTCBB:SWME - News) is pleased to announce that Wal-Mart Canada Corp. is now offering O24 Pain Neutralizer nationwide in both the 1 ounce bottle size and the convenient 20-count towelettes. "Swiss Medica is pleased that our line of O24 products will be available in another key retailer," announced Anne Dundon, Vice President Sales. "We look forward to our partnership with Wal-Mart Canada Corp."
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com ,www.O24zone.com and www.pmsescape.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24 is widely available throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.
Swiss Medica also manufactures PMS Escape® which holds US Patent #'s 5760014 and 5612320. PMS Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: www.pmsescape.com for additional information and ordering details.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.
Swiss Medica, Inc. (OTC Bulletin Board:SWME - News)
-------------------------------------------------------------------------------- Contact: Swiss Medica Inc. Investor Relations Contact: David Jones 1 (866) 485-4243 OR Fusion Communications Public Relations Contact: Dean Mailey (604) 218-6767 dean@fusioncom.ca OR Stern & Co. Financial Media Contact: Stan Froelich, VP, Media Relations (212) 888-0044 sfroelich@sternco.com
Swiss Medica Provides Third Quarter Store Count Guidance for O24'TM' Pain Neutralizer, O24 Fibromylagia'TM' and PMS Escape'TM' Friday August 5, 6:00 am ET
TORONTO--(BUSINESS WIRE)--Aug. 5, 2005--Swiss Medica, Inc. (OTCBB:SWME - News) is pleased to reaffirm that the Company's flagship O24(TM) Pain Neutralizer product will be available in excess of 19,000 retail stores throughout the United States and Canada by September 30, 2005. Management anticipates that the recently launched O24 Fibromyalgia(TM) will be available in approximately 14,000 retail stores across the United States by September 30, 2005. In addition, PMS Escape(TM) will be available in over 5,300 retail outlets throughout the United States by August 31, 2005.
Specific retail store locators for both O24(TM) Pain Neutralizer and O24 Fibromyalgia(TM) can be found at www.O24zone.com. Specific retail store locators will be available for PMS Escape(TM) by the end of August at www.pmsescape.com. Swiss Medica will continue its extensive and aggressive marketing, public relations, and sampling programs to support the increased national distribution for all three products.
About Swiss Medica, Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com,www.O24zone.com and www.pmsescape.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24 is widely available throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.
Swiss Medica also manufactures PMS Escape® which holds US Patent #'s 5760014 and 5612320. PMS Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: www.pmsescape.com for additional information and ordering details.
Posts: 424 | From: Baltimore, MD | Registered: Apr 2004
| IP: Logged |
posted
News out!! ========================= Swiss Medica Launches Medical Channel Distribution of 024 Fibromyalgia Monday August 8, 6:00 am ET
TORONTO--(BUSINESS WIRE)--Aug. 8, 2005--Swiss Medica Inc. (OTCBB:SWME - News) is pleased to announce that ProHealth has begun offering O24 Fibromyalgia to its customers through its online website, www.prohealth.com. Customers can immediately directly order O24 Fibromyalgia by searching for product code 5099 or "soreness" on the ProHealth website. ProHealth is beginning a substantial promotion for the O24 Fibromyalgia product to its customer base this week. ADVERTISEMENT
Pro Health's CEO, Dennis Schoen, stated, "As the largest private fundraiser for Fibromyalgia and Chronic Fatigue Syndrome, Pro Health is pleased to provide a well-researched product to its patients and professional customers. We look forward to hearing positive results from our customers."
ProHealth, Inc. the publisher of the largest Fibromyalgia and Chronic Fatigue Syndrome web site, Immune Support.com is proud to introduce Swiss Medica's 024 Fibromyalgia product. Pro Health's multi-pronged launch of this product, formulated to improve the lives of Fibromyalgia patients, includes an emailing to its subscribers and prominent inclusion on Immune Support, where eight million people visited last year for the latest news on Fibromyalgia and Chronic Fatigue Syndrome research, interviews, treatment options and support. Additionally, Pro Health will actively support distribution through its network of 5,000 physicians.
"We now have a sales force on the ground detailing health care professionals," said Grant Johnson, President and COO of Swiss Medica. "This element broadens and accelerates our continued growth."
O24 Fibromyalgia is the first product of its kind developed to specifically address the symptoms of long term pain associated with the fibromyalgia syndrome and is a patented and clinically tested, strong and safe, all-natural, over-the-counter health product. Management anticipates that the recently launched O24 Fibromyalgia(TM) will be available in approximately 14,000 retail stores across the United States by September 30, 2005.
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.O24zone.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States, Canada and in Europe. O24 is widely available throughout Canada in leading pharmacies and natural food stores. It is currently sold in an increasing number of pharmacies throughout the United States. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.
Swiss Medica also manufactures PMS Escape® which holds US Patent #'s 5760014 and 5612320. PMS Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: www.pmsescape.com for additional information and ordering details.
Posts: 424 | From: Baltimore, MD | Registered: Apr 2004
| IP: Logged |
Huge potential, nice growth, adding distributors monthly, real products.
========================= SWME CVS/Pharmacy Now Offering Swiss Medica's PMS Escape Product CCNMatthews - August 9, 2005 6:03 AM (EDT)
TORONTO, ONTARIO, Aug 9, 2005 (CCNMatthews via COMTEX) -- Swiss Medica, Inc. (OTCBB:SWME) is pleased to announce that CVS/Pharmacy is now offering the PMS Escape product nationwide.
"We are excited CVS/pharmacy has become our first U.S. national pharmacy chain to carry PMS Escape," said Wendy Kramer, Swiss Medica's Vice President. "We believe this will offer millions of women the opportunity to purchase PMS Escape - a clinically studied, patented, safe and effective product for the normal mood and appetite symptoms associated with premenstrual syndrome."
Posts: 424 | From: Baltimore, MD | Registered: Apr 2004
| IP: Logged |
Swiss Medica Reports Strong Initial Sales Of New O24 Fibromyalgia At Prohealth.com Monday August 22, 9:44 am ET O24 Fibromyalgia Rockets To Number 3 Spot for Products Sold Through Prohealth.com and receives high praise from consumers using the product
TORONTO--(BUSINESS WIRE)--Aug. 22, 2005-- Swiss Medica, Inc. (OTCBB:SWME - News) today announced that its recently-launched O24 Fibromyalgia pain reliever is enjoying strong sales through the ProHealth medical channel distribution. In early August, ProHealth began offering O24 Fibromyalgia to its customers through its online website, www.prohealth.com - and within days, the product shot straight to the Number 3 spot in terms of volumes of product sold through Prohealth.com. ADVERTISEMENT
"We have received very positive feedback from both our Fibromyalgia and general pain audiences regarding 024 Fibromyalgia" says ProHealth President Dennis Schoen. "The product has earned a 4.5 on 1-5 point scale, with 5 being the most efficacious. Customer comments range from benefits for Fibromyalgia symptoms as well as for helping patients dealing with other non-related pain issues."
ProHealth, Inc. the publisher of the largest Fibromyalgia and Chronic Fatigue Syndrome web site, Immune Support.com introduced Swiss Medica's O24 Fibromyalgia product on August 8, 2005. ProHealth's multi-pronged launch of this product, formulated to improve the lives of Fibromyalgia patients, included an emailing to its subscribers and prominent inclusion on Immune Support, where eight million people visited last year for the latest news on Fibromyalgia and Chronic Fatigue Syndrome research, interviews, treatment options and support. Additionally, ProHealth is actively supporting distribution through its network of 5,000 physicians.
The early success of the product has also been warmly received by the National Fibromyalgia Association (NFA). In June, O24 Fibromyalgia became the first product to carry the NFA's new official Seal of Approval.
O24 Fibromyalgia is the first product of its kind developed to specifically address the symptoms of long term pain associated with fibromyalgia syndrome and is a patented and clinically tested, strong and safe, all-natural, over-the-counter health product. Swiss Medica is the owner, maker and distributor of this product. Swiss Medica president, Grant Johnson said that he is highly encouraged by the resoundingly positive response from consumers using the Prohealth.com website. O24 Fibromyalgia will be available in national pharmacies in the United States in the fall of 2005.
"This is a real validation about the demand we see for this product - and it is great to see such strong initial interest from the health care professionals who use ProHealth," he said. "We have known for some time that Fibromyalgia sufferers were crying out for a natural, non-prescription, safe product that could them with pain relief - and we are very happy that we were able to develop it and bring it to market."
Fibromyalgia is typically characterized by widespread musculoskeletal aches, pain and stiffness, soft tissue tenderness, general fatigue and sleep disturbances. The most common sites of pain include the neck, back, shoulders, pelvic girdle and hands. Fibromyalgia patients experience a range of symptoms, varying in intensity that can fluctuate over time. The NFA estimates that the average family doctor sees at least one patient each day who is suffering from fibromyalgia and that the syndrome could cost U.S. economy as much as $10 billion a year in lost productivity.
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com,www.O24zone.com and www.pmsescape.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24 is widely available throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.
Swiss Medica also manufactures PMS Escape® which holds US Patent #'s 5760014 and 5612320. PMS Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: www.pmsescape.com for additional information and ordering details.
Posts: 424 | From: Baltimore, MD | Registered: Apr 2004
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
